Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ariva debate

This article was originally published in The Tan Sheet

Executive Summary

FDA denies 2001 petition by Campaign for Tobacco-Free Kids and 18 other public health organizations to regulate Star Scientific's Ariva "cigaletts" as either an unapproved new drug or adulterated food, the campaign reports in Aug. 29 1release. Ariva - a compressed tobacco lozenge - is currently regulated as a tobacco product under the Comprehensive Smokeless Tobacco Health Education Act (1986) (2"The Tan Sheet" December 24, 2001, p. 5). According to CTFK, FDA claims it lacks authority to regulate Ariva based on a U.S. Supreme Court decision in 2000 that the agency does not have authority over traditional tobacco products as customarily marketed. Ariva is "clearly neither a traditional tobacco product nor is it marketed like one," CTFK contends. "It is used and consumed like a food and has been marketed as a drug. We believe FDA's decision is wrong and places consumers in unnecessary jeopardy"...
Advertisement

Related Content

Ariva Tobacco Lozenges Outside FDA Purview, Marketer Maintains
Ariva Tobacco Lozenges Outside FDA Purview, Marketer Maintains

Topics

Advertisement
UsernamePublicRestriction

Register

PS095861

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel